Yüklüyor......
Willingness to Take Buprenorphine/Naloxone Among People Who Use Opioids in Vancouver, Canada
OBJECTIVES: Opioid agonist therapy is the cornerstone of treatment of opioid use disorder. In Canada, buprenorphine/naloxone has recently been adopted as the first line agonist therapy given its comparable effectiveness to methadone and superior safety profile. This study examines factors associated...
Kaydedildi:
| Yayımlandı: | Drug Alcohol Depend |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894418/ https://ncbi.nlm.nih.gov/pubmed/31706251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2019.107672 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|